HCPCS Level II · Drugs administered other than oral method
J1050Injection, medroxyprogesterone acetate, 1 mg
✓ Active
Source: CMS HCPCS quarterly update, October 2026. Page updated September 29, 2026.
About J1050
J1050 is an HCPCS Level II code in the J series (drugs administered other than oral method), describing injection, medroxyprogesterone acetate, 1 mg.
It was added to HCPCS effective 01/01/2013.
Its Medicare coverage code is "C", meaning coverage is left to the Medicare contractor's judgment.
Details
- Short description
- Medroxyprogesterone acetate
- Date added
- 01/01/2013
- Action effective
- 01/01/2013
- BETOS
- O1E
Related J10xx codes
- J1000Injection, depo-estradiol cypionate, up to 5 mg
- J1010Injection, methylprednisolone acetate, 1 mg
- J1071Injection, testosterone cypionate, 1 mg
- J1072Injection, testosterone cypionate (azmiro), 1 mg
- J1073Testosterone pellet, implant, 75 mg
- J1095Injection, dexamethasone 9 percent, intraocular, 1 microgram
- J1096Dexamethasone, lacrimal ophthalmic insert, 0.1 mg
- J1097Phenylephrine 10.16 mg/ml and ketorolac 2.88 mg/ml ophthalmic irrigation solution, 1 ml
- J1098Articaine ophthalmic, 8% solution, 0.4 ml
Common questions about J1050
Is HCPCS J1050 still valid?
- Yes. J1050 is active in the CMS October 2026 HCPCS file.
Does Medicare cover J1050?
- Its coverage code is "C": coverage is left to the Medicare contractor's judgment. Check the local coverage determination for your region.